About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
GRACE
cancergrace.org
Podcast Series
Targeted Therapies in Lung Cancer 2023
ASCO® 2023
Lung Cancer OncTalk
Blood Cancer OncTalk
2022 Melanoma Video Library
OncTalk 2022
ASCO Lung Review 2022
ASCO and ESMO Lung Recap
2021 Targeted Therapies Patient Forum
COVID-19
Lung
Hematologic Oncology
Head and Neck
Brain
Palliative
Genitourinary
General
Breast
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
ASCO & ESMO Lung Recap: Amivantamab + Lazertinib in EGFR, Patritumab Deruxtecan in EGFR+ Acquired Resistance
By
GRACE
FEATURING
Jack West
,
Isabel Preeshagul
,
Joan Schiller
By
GRACE
FEATURING
Jack West
,
Isabel Preeshagul
,
Joan Schiller
80 views
February 9, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:35
University of Colorado Division of Hematology
2024 Updates in PV/ET
Feat.
B. McMahon
Featured Video
20:25
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
ASCO and ESMO Lung Recap
06:00
GRACE
ASCO & ESMO Lung Recap: ctDNA and NSCLC
Feat.
J. West,
I. Preeshagul,
J. Schiller
11:20
CancerGRACE
ASCO & ESMO Lung Recap on the Surgical Outcomes & CheckMate …
Feat.
J. West,
I. Preeshagul,
J. Schiller
13:50
CancerGRACE
ASCO & ESMO Lung Recap on the IMpower010 Trial: Atezo After Chem…
Feat.
J. West,
I. Preeshagul,
J. Schiller
08:03
CancerGRACE
ASCO & ESMO Lung Recap: FDA Analysis of IO +/- Chemo in Advanced…
Feat.
J. West,
I. Preeshagul,
J. Schiller
06:28
GRACE
ASCO & ESMO Lung Recap on the Poseidon Trial: Durvalumab +/- Tre…
Feat.
J. West,
I. Preeshagul,
J. Schiller
07:36
CancerGRACE
ASCO & ESMO Lung Recap: Carbo/Pemetrexed/Pembro and Acquired Res…
Feat.
J. West,
I. Preeshagul,
J. Schiller
06:07
GRACE
ASCO & ESMO Lung Recap: Atezolizumab for mNSCLC With Brain Mets
Feat.
J. West,
I. Preeshagul,
J. Schiller
05:16
GRACE
ASCO & ESMO Lung Recap on Sotorasib in KRAS G12C-Mutated NSCLC: …
Feat.
J. West,
I. Preeshagul,
J. Schiller
06:07
GRACE
ASCO & ESMO Lung Recap on Amivantamab and Mobocertinib for EGFR …
Feat.
J. West,
I. Preeshagul,
J. Schiller
09:18
GRACE
ASCO & ESMO Lung Recap: Amivantamab + Lazertinib in EGFR, Patrit…
Feat.
J. West,
I. Preeshagul,
J. Schiller
07:58
GRACE
ASCO & ESMO Lung Recap on Overall Biomarker Testing in MYLUNG Co…
Feat.
J. West,
I. Preeshagul,
J. Schiller
05:17
GRACE
ASCO & ESMO Lung Recap: 2L Lurbinectedin in SCLC - Phase 3 Atlan…
Feat.
J. West,
I. Preeshagul,
J. Schiller
